Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China
Clinical trial NCT05624112 · COMPLETED
Trial details
- NCT number
- NCT05624112
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-25
- Primary completion
- 2024-01-25
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.